These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6676608)

  • 1. [Humoral and cellular immunity to selected viral antigens in children from the Bełchatów Industrial Region].
    Stempień R; Słowińska I; Wardecka J; Deroń Z; Imbs D; Jankowski M; Jarzabek Z; Kańtoch M
    Med Dosw Mikrobiol; 1983; 35(3-4):259-68. PubMed ID: 6676608
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
    J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella susceptibility predicts measles susceptibility: implications for postpartum immunization.
    Libman MD; Behr MA; Martel N; Ward BJ
    Clin Infect Dis; 2000 Dec; 31(6):1501-3. PubMed ID: 11096023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prevalence of measles, rubella, mumps and chickenpox antibodies in a population of health care workers].
    Oliveira J; da Cunha S; Côrte-Real R; Sampaio L; Dais N; Meliço-Silvestre A
    Acta Med Port; 1995 Apr; 8(4):206-16. PubMed ID: 7625214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000-2004.
    Eick AA; Hu Z; Wang Z; Nevin RL
    Vaccine; 2008 Jan; 26(4):494-501. PubMed ID: 18155326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroepidemiology of measles, mumps and rubella.
    Wkly Epidemiol Rec; 1992 Jul; 67(31):231-3. PubMed ID: 1498027
    [No Abstract]   [Full Text] [Related]  

  • 7. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Susceptibility to measles, rubella and parotitis in young adults].
    Bayas JM; Vilella A; Vidal J; Nebot X; Carbó JM; Navarro G; Prat A; Asenjo MA; Salleras L
    Med Clin (Barc); 1996 Apr; 106(15):561-4. PubMed ID: 8656753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of antibody to measles, mumps, and rubella by age.
    Morgan-Capner P; Wright J; Miller CL; Miller E
    BMJ; 1988 Sep; 297(6651):770-2. PubMed ID: 3142541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of measles, rubella and mumps viruses in multiple sclerosis.
    Pille ER; Mzokova VM; Andreeva AP; Andzhaparidze OG
    Acta Virol; 1977 Mar; 21(2):139-45. PubMed ID: 17282
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the immune status against the viruses of measles, mumps, rubella, and hepatitis B in a cohort of students from the province of Como].
    Fraizzoli G; Sesana BM
    Ann Ig; 1989; 1(5):1163-71. PubMed ID: 2483899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte blast transformation response of seropositive and seronegative subjects to herpes simplex, rubella, mumps and measles virus antigens.
    Ilonen J
    Acta Pathol Microbiol Scand C; 1979 Apr; 87C(2):151-7. PubMed ID: 220840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design.
    Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Poland GA
    Vaccine; 2007 Apr; 25(16):3090-100. PubMed ID: 17280755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.
    Ovsyannikova IG; Pankratz VS; Vierkant RA; Jacobson RM; Poland GA
    J Infect Dis; 2006 Mar; 193(5):655-63. PubMed ID: 16453260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of RT-PCR assay of oral fluid for diagnosis and surveillance of measles, mumps and rubella.
    Jin L; Vyse A; Brown DW
    Bull World Health Organ; 2002; 80(1):76-7. PubMed ID: 11884979
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination.
    Jokinen S; Osterlund P; Julkunen I; Davidkin I
    J Infect Dis; 2007 Sep; 196(6):861-7. PubMed ID: 17703416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of molecular testing to confirm measles, mumps and rubella in immunised individuals.
    Speers DJ; Dowse GK
    Med J Aust; 2015 Apr; 202(6):297-8. PubMed ID: 25832147
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigation on the role of viral antibodies in the pathogenesis of multiple sclerosis.
    Matveeva TV; Pille ER; Diakonova IN; Andreeva AP
    Acta Virol; 1980 Dec; 24(6):415-20. PubMed ID: 6111202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus antibodies in patients with multiple sclerosis.
    Salmi AA
    Ann Clin Res; 1973 Oct; 5(5):319-29. PubMed ID: 4365526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.